BrainsWay Ltd.

NASDAQ:BWAY

Medical - Devices

Healthcare
$8.98 +0.35%

+$0.05 today

Market cap
$352.22M
Beta
0.15
P/E (TTM)
61.7
EPS (TTM)
$0.23
52W Low $5.42High $17.35

Volume 0.15M

Average 0.15M

BWAY Net Receivables

Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.

BrainsWay Ltd.NASDAQ: BWAY

Net Receivables · Q1 FY2026 · quarter ended Mar 2026

Net receivables rises 8.3% from a year ago

Net receivables stood at $7.53M at the end of Q1 FY2026, up 8.3% from a year earlier and up 83.2% from the prior quarter. Over 3 fiscal years it compounded at -5.3% a year.

Context

  • Net receivables amounted to 6.4% of total assets at the end of Q1 FY2026, down 0.5 pp from a year earlier.
  • Net receivables increased in 1 of the last 3 fiscal years.

What to watch

Whether net receivables keeps rising in the next quarterly balance sheet after a +8.3% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$7.53M+83.2% QoQ
Last fiscal yearDec 2025
$4.11M-10.6% YoY
Year agoMar 2025
$6.95M+8.3% since
Net Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+8.3%——
1 year-10.6%——
3-year CAGR-5.3%——
5-year CAGR——
10-year CAGR——

Net Receivables history

USD · from the balance sheet

Latest · FY2025
4.11M USD
Year-over-year change
-10.6%
4-year CAGR
-10.2%

Net Receivables vs competitors

How BWAY compares with its peers on the latest reported figures

  • BWAY's Mar 2026 net receivables of $7.53M is the 3rd highest of the 4 companies compared; the peer median is $14.79M.
  • Its year-over-year change of +8.3% is the highest of 4, against a peer median of -39.7%.
  • Net receivables amounts to 6.4% of total assets for BWAY, versus a peer median of 12.9%.
BWAY Competitors Peer median
Net Receivables for BWAY and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
STIMNeuronetics, Inc.Mar 2026$16.21M -39.7%+6.9%12.9%
NPCENeuroPace, Inc.Mar 2026$14.79M -4.2%+25.2%15.0%
BWAYBrainsWay Ltd.Mar 2026$7.53M +8.3%-5.3%6.4%
HSDTSolana CompanyMar 2026$0 -100.0%—0.0%
MOBIMobia Medical, Inc. Common Stock—— ———
Peer median (excluding BWAY) $14.79M-39.7%+16.1%12.9%

Competitors are the stored peer set for BWAY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents16.92M47.58M10.52M69.35M67.7M
Short-term Investments40.43M035.47M01.43M
Net Receivables6.33M4.84M3.78M4.6M4.11M
Inventory200K3.84M3.72M4.43M7.13M
Other Current Assets388K1.83M691K1.3M4.51M
Total Current Assets65.45M58.09M55.47M79.67M84.89M
Property, Plant & Equipment (Net)9.33M5.35M5.79M11.95M12.17M
Goodwill00000
Intangible Assets00000
Long-term Investments000014.34M
Tax Assets0276K01.06M0
Other Non-current Assets954K766K1.72M1.64M1.52M
Total Non-current Assets10.29M6.39M7.51M14.65M28.03M
Total Assets75.73M64.48M62.97M94.32M112.92M
Account Payables1.1M1.12M758K2.87M2.43M
Short-term Debt00000
Tax Payables18K0504K268K0
Deferred Revenue2.2M1.48M3.51M5.73M12.23M
Other Current Liabilities2.12M2.93M2.07M2.72M0
Total Current Liabilities9.07M8.14M9.76M15.35M22.16M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)3.16M4.67M5.31M9.43M11.79M
Other Non-current Liabilities5.93M6.02M6.08M2.43M0
Total Non-current Liabilities9.34M10.94M11.63M16.66M17.53M
Total Liabilities18.41M19.08M21.39M32M39.7M
Common Stock363K364K367K413K430K
Retained Earnings(83.76M)(97.11M)(101.3M)(98.38M)(90.75M)
Accumulated OCI(2.19M)(2.19M)(2.19M)(2.19M)(2.19M)
Other Stockholders Equity5.34M6.18M4.36M4.87M3.51M
Minority Interest00000
Total Equity57.33M45.4M41.58M62.31M73.22M
Total Debt754K488K471K5.62M6.82M
Net Debt(16.17M)(47.09M)(10.05M)(63.72M)(60.88M)

BrainsWay Ltd.

NASDAQ:BWAY

Intrinsic Alpha fair value

Locked

Current Price

$8.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.